General Detection and Isolation of Specific Cells by Binding of Labeled Molecules
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application PCT/DK2015/050169, filed Jun 15, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,402,373 | General Detection and Isolation of Specific Cells by Binding of Labeled Molecules In force · High confidence | Immudex APS | In force | High confidence | ||
| US 11,585,806 | General Detection and Isolation of Specific Cells by Binding of Labeled Molecules In force · High confidence | Immudex APS | In force | High confidence | ||
| US 11,668,705 | General Detection and Isolation of Specific Cells by Binding of Labeled Molecules In force · High confidence | Immudex APS | In force | High confidence | ||
| Application 18/304,028 | General Detection and Isolation of Specific Cells by Binding of Labeled Molecules Pending Not granted | Immudex APS | Pending | Not granted | not computed |
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Immudex APS.
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.